Helius Medical (HSDT) Stock Forecast, Price Target & Predictions
HSDT Stock Forecast
Helius Medical stock forecast is as follows: a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
HSDT Analyst Ratings
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 16, 2024 | Maxim Group | Buy | Reduce | Downgrade |
Dec 20, 2022 | Maxim Group | - | Buy | Initialise |
Nov 17, 2022 | Zacks Investment Research | - | Buy | Upgrade |
Aug 24, 2022 | Roth Capital | - | Buy | Initialise |
Helius Medical Financial Forecast
Helius Medical Revenue Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | $143.00K | $256.00K | $111.00K | $282.00K | $196.00K | $119.00K | $190.00K | $258.00K | $109.00K | $71.00K | $84.00K | $191.00K | $131.00K | $133.00K | $207.00K | $152.00K | $150.00K | $518.00K | $677.00K |
Avg Forecast | $301.00K | $225.00K | $239.00K | $205.00K | $268.00K | $150.00K | $150.00K | $110.00K | $249.67K | $345.00K | $188.33K | $275.00K | $262.33K | $167.50K | $360.00K | $160.00K | $100.00K | $84.50K | $95.00K | $93.50K | $170.00K | $100.00K | $100.00K | $300.00K | $200.00K | $300.00K | $300.00K | $150.00K |
High Forecast | $301.00K | $225.00K | $239.00K | $205.00K | $268.00K | $150.00K | $150.00K | $110.00K | $249.67K | $345.00K | $188.33K | $275.00K | $262.33K | $167.50K | $360.00K | $160.00K | $100.00K | $84.50K | $95.00K | $93.50K | $170.00K | $100.00K | $100.00K | $300.00K | $200.00K | $300.00K | $300.00K | $150.00K |
Low Forecast | $301.00K | $225.00K | $239.00K | $205.00K | $268.00K | $150.00K | $150.00K | $110.00K | $249.67K | $345.00K | $188.33K | $275.00K | $262.33K | $167.50K | $360.00K | $160.00K | $100.00K | $84.50K | $95.00K | $93.50K | $170.00K | $100.00K | $100.00K | $300.00K | $200.00K | $300.00K | $300.00K | $150.00K |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Surprise % | - | - | - | - | - | - | - | - | - | 0.41% | 1.36% | 0.40% | 1.07% | 1.17% | 0.33% | 1.19% | 2.58% | 1.29% | 0.75% | 0.90% | 1.12% | 1.31% | 1.33% | 0.69% | 0.76% | 0.50% | 1.73% | 4.51% |
Helius Medical EBITDA Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
EBITDA | - | - | - | - | - | - | - | - | - | $-2.22M | $-3.22M | $-4.97M | $-321.00K | $-4.03M | $-2.98M | $-4.71M | $-4.03M | $-3.98M | $-6.29M | $-3.54M | $-3.37M | $-3.75M | $-3.91M | $-3.08M | $-5.76M | $-5.83M | $-11.40M | $-14.93M |
Avg Forecast | $-301.00K | $-225.00K | $-239.00K | $-205.00K | $-268.00K | $-150.00K | $-150.00K | $-110.00K | $-249.67K | $-345.00K | $-188.33K | $-275.00K | $-262.33K | $-167.50K | $-360.00K | $-4.20M | $-100.00K | $-84.50K | $-4.21M | $-93.50K | $-170.00K | $-100.00K | $-100.00K | $-300.00K | $-200.00K | $-300.00K | $-300.00K | $-150.00K |
High Forecast | $-301.00K | $-225.00K | $-239.00K | $-205.00K | $-268.00K | $-150.00K | $-150.00K | $-110.00K | $-249.67K | $-345.00K | $-188.33K | $-275.00K | $-262.33K | $-167.50K | $-360.00K | $-3.36M | $-100.00K | $-84.50K | $-3.37M | $-93.50K | $-170.00K | $-100.00K | $-100.00K | $-300.00K | $-200.00K | $-300.00K | $-300.00K | $-150.00K |
Low Forecast | $-301.00K | $-225.00K | $-239.00K | $-205.00K | $-268.00K | $-150.00K | $-150.00K | $-110.00K | $-249.67K | $-345.00K | $-188.33K | $-275.00K | $-262.33K | $-167.50K | $-360.00K | $-5.04M | $-100.00K | $-84.50K | $-5.06M | $-93.50K | $-170.00K | $-100.00K | $-100.00K | $-300.00K | $-200.00K | $-300.00K | $-300.00K | $-150.00K |
Surprise % | - | - | - | - | - | - | - | - | - | 6.43% | 17.09% | 18.09% | 1.22% | 24.03% | 8.27% | 1.12% | 40.27% | 47.15% | 1.49% | 37.86% | 19.80% | 37.46% | 39.08% | 10.26% | 28.79% | 19.44% | 38.01% | 99.55% |
Helius Medical Net Income Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Net Income | - | - | - | - | - | - | - | - | - | $-3.66M | $-1.65M | $-1.08M | $-7.19M | $2.96M | $-4.57M | $-3.91M | $-4.10M | $-4.69M | $-5.98M | $-3.36M | $-2.53M | $-3.48M | $-3.36M | $-4.76M | $-4.80M | $-5.59M | $-186.00K | $1.32M |
Avg Forecast | $-1.26M | $-1.31M | $-1.28M | $-2.22M | $-2.22M | $-2.67M | $-1.26M | $-12.69M | $-9.50M | $-15.11M | $-14.69M | $-13.85M | $-16.37M | $-26.44M | $-141.01M | $-4.27M | $-146.05M | $-220.33M | $-4.26M | $-190.11M | $-352.53M | $-396.60M | $-528.80M | $-705.06M | $-925.39M | $-969.46M | $-991.49M | $2.62M |
High Forecast | $-1.26M | $-1.31M | $-1.28M | $-2.22M | $-2.22M | $-2.67M | $-1.26M | $-12.69M | $-9.50M | $-15.11M | $-14.69M | $-13.85M | $-16.37M | $-26.44M | $-141.01M | $-3.42M | $-146.05M | $-220.33M | $-3.41M | $-190.11M | $-352.53M | $-396.60M | $-528.80M | $-705.06M | $-925.39M | $-969.46M | $-991.49M | $3.15M |
Low Forecast | $-1.26M | $-1.31M | $-1.28M | $-2.22M | $-2.22M | $-2.67M | $-1.26M | $-12.69M | $-9.50M | $-15.11M | $-14.69M | $-13.85M | $-16.37M | $-26.44M | $-141.01M | $-5.12M | $-146.05M | $-220.33M | $-5.11M | $-190.11M | $-352.53M | $-396.60M | $-528.80M | $-705.06M | $-925.39M | $-969.46M | $-991.49M | $2.10M |
Surprise % | - | - | - | - | - | - | - | - | - | 0.24% | 0.11% | 0.08% | 0.44% | -0.11% | 0.03% | 0.92% | 0.03% | 0.02% | 1.40% | 0.02% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.00% | 0.51% |
Helius Medical SG&A Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
SG&A | - | - | - | - | - | - | - | - | - | $2.20M | $2.57M | $2.87M | $1.97M | $3.39M | $2.46M | $2.82M | $2.38M | $2.86M | $4.74M | $2.20M | $2.09M | $2.37M | $2.39M | $2.86M | $3.81M | $4.29M | $3.85M | $4.58M |
Avg Forecast | $4.63M | $3.46M | $3.68M | $3.15M | $4.12M | $2.31M | $2.31M | $1.69M | $3.84M | $5.31M | $2.90M | $4.23M | $4.04M | $2.58M | $5.54M | $2.46M | $1.54M | $1.30M | $1.46M | $1.44M | $2.61M | $1.54M | $1.54M | $4.61M | $3.08M | $4.61M | $4.61M | $2.31M |
High Forecast | $4.63M | $3.46M | $3.68M | $3.15M | $4.12M | $2.31M | $2.31M | $1.69M | $3.84M | $5.31M | $2.90M | $4.23M | $4.04M | $2.58M | $5.54M | $2.46M | $1.54M | $1.30M | $1.46M | $1.44M | $2.61M | $1.54M | $1.54M | $4.61M | $3.08M | $4.61M | $4.61M | $2.31M |
Low Forecast | $4.63M | $3.46M | $3.68M | $3.15M | $4.12M | $2.31M | $2.31M | $1.69M | $3.84M | $5.31M | $2.90M | $4.23M | $4.04M | $2.58M | $5.54M | $2.46M | $1.54M | $1.30M | $1.46M | $1.44M | $2.61M | $1.54M | $1.54M | $4.61M | $3.08M | $4.61M | $4.61M | $2.31M |
Surprise % | - | - | - | - | - | - | - | - | - | 0.41% | 0.89% | 0.68% | 0.49% | 1.32% | 0.44% | 1.15% | 1.54% | 2.20% | 3.25% | 1.53% | 0.80% | 1.54% | 1.56% | 0.62% | 1.24% | 0.93% | 0.83% | 1.99% |
Helius Medical EPS Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
EPS | - | - | - | - | - | - | - | - | - | $-5.49 | $-0.00 | $-0.04 | $-0.26 | $0.35 | $-1.16 | $-1.03 | $-1.31 | $-2.28 | $-2.42 | $-1.51 | $-1.12 | $-2.41 | $-2.32 | $-7.09 | $-6.05 | $-7.17 | $14.96 | $23.85 |
Avg Forecast | $-0.50 | $-0.52 | $-0.51 | $-0.88 | $-0.88 | $-1.06 | $-0.50 | $-5.04 | $-3.77 | $-6.00 | $-5.83 | $-5.50 | $-6.50 | $-10.50 | $-56.00 | $-56.50 | $-58.00 | $-87.50 | $-80.75 | $-75.50 | $-140.00 | $-157.50 | $-210.00 | $-280.00 | $-367.50 | $-385.00 | $-393.75 | $-446.25 |
High Forecast | $-0.50 | $-0.52 | $-0.51 | $-0.88 | $-0.88 | $-1.06 | $-0.50 | $-5.04 | $-3.77 | $-6.00 | $-5.83 | $-5.50 | $-6.50 | $-10.50 | $-56.00 | $-56.50 | $-58.00 | $-87.50 | $-80.75 | $-75.50 | $-140.00 | $-157.50 | $-210.00 | $-280.00 | $-367.50 | $-385.00 | $-393.75 | $-446.25 |
Low Forecast | $-0.50 | $-0.52 | $-0.51 | $-0.88 | $-0.88 | $-1.06 | $-0.50 | $-5.04 | $-3.77 | $-6.00 | $-5.83 | $-5.50 | $-6.50 | $-10.50 | $-56.00 | $-56.50 | $-58.00 | $-87.50 | $-80.75 | $-75.50 | $-140.00 | $-157.50 | $-210.00 | $-280.00 | $-367.50 | $-385.00 | $-393.75 | $-446.25 |
Surprise % | - | - | - | - | - | - | - | - | - | 0.92% | 0.00% | 0.01% | 0.04% | -0.03% | 0.02% | 0.02% | 0.02% | 0.03% | 0.03% | 0.02% | 0.01% | 0.02% | 0.01% | 0.03% | 0.02% | 0.02% | -0.04% | -0.05% |
Helius Medical Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
BJDX | Bluejay Diagnostics | $0.07 | $10.00 | 14185.71% | Buy |
HSDT | Helius Medical | $0.51 | $5.00 | 880.39% | Buy |
RPID | Rapid Micro Biosystems | $1.08 | $8.00 | 640.74% | Hold |
AZYO | Elutia | $1.49 | $10.25 | 587.92% | Buy |
SGHT | Sight Sciences | $4.66 | $10.25 | 119.96% | Hold |
HSCS | Heart Test Laboratories | $2.73 | $3.00 | 9.89% | Buy |
HSDT Forecast FAQ
Is Helius Medical a good buy?
Yes, according to 3 Wall Street analysts, Helius Medical (HSDT) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 66.67% of HSDT's total ratings.
What are Helius Medical's analysts' financial forecasts?
Helius Medical's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $678K (high $678K, low $678K), average EBITDA is $-678K (high $-678K, low $-678K), average net income is $-18.835M (high $-18.835M, low $-18.835M), average SG&A $10.43M (high $10.43M, low $10.43M), and average EPS is $-7.48 (high $-7.48, low $-7.48). HSDT's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $970K (high $970K, low $970K), average EBITDA is $-970K (high $-970K, low $-970K), average net income is $-6.069M (high $-6.069M, low $-6.069M), average SG&A $14.92M (high $14.92M, low $14.92M), and average EPS is $-2.41 (high $-2.41, low $-2.41).
Did the HSDT's actual financial results beat the analysts' financial forecasts?
Based on Helius Medical's last annual report (Dec 2023), the company's revenue was $644K, which missed the average analysts forecast of $1.06M by -39.13%. Apple's EBITDA was $-12.428M, beating the average prediction of $-1.058M by 1074.67%. The company's net income was $-8.85M, missing the average estimation of $-53.148M by -83.35%. Apple's SG&A was $9.27M, missing the average forecast of $16.27M by -43.03%. Lastly, the company's EPS was $-0.0146, missing the average prediction of $-21.107 by -99.93%. In terms of the last quarterly report (Sep 2023), Helius Medical's revenue was $143K, missing the average analysts' forecast of $345K by -58.55%. The company's EBITDA was $-2.218M, beating the average prediction of $-345K by 542.90%. Helius Medical's net income was $-3.663M, missing the average estimation of $-15.108M by -75.76%. The company's SG&A was $2.2M, missing the average forecast of $5.31M by -58.62%. Lastly, the company's EPS was $-5.49, missing the average prediction of $-6 by -8.50%